We have located links that may give you full text access.
Evaluation of vascular access complications in acute and chronic hemodialysis.
Journal of Vascular Access 2004 April
PURPOSE: This work aimed to determine the incidence of vascular access (VA)-related complications of temporary venous catheters in acute hemodialysis (HD) prescription, to study the survival rate of chronic HD patients who began HD with a catheter insertion and to evaluate associated complications.
METHODS: The patients were classified into two groups. Group I, patients in whom venous catheters were inserted (652 patients). Group II, 80 patients with end-stage renal disease (ESRD) in whom an arteriovenous fistula (AVF) was established.
RESULTS: Complications in the femoral approach were bleeding from a femoral artery wall laceration in only 6/600 patients (1%), successfully repaired in all patients, bleeding from a punctured femoral artery in 30 patients (5%), the incidence of infection and removal was 40%. Other complications included groin hematoma in 3 patients (0.5%) and catheter thrombosis in 45 patients (7.5%). In the jugular vein approach, infection occurred in 6/30 patients (20%), thrombosis in 9 patients (30%), and accidental withdrawal in 2 patients (6.7%). In the subclavian vein approach, catheter dysfunction was found in 7/22 patients (32%), infection in 10 patients (45.5%), and failure to cannulate the vein in 3 patients (13.6%). In group II, limb edema was found in 14/80 patients (17.5%), hematoma in 5 patients (6.3%), accidental trauma to the fistula in 2 patients (2.5%) and fistula stenosis in 15 patients (18.8%). Patients who began HD with a catheter had higher mortality than those who began with an AVF (12 months survival, respectively, 60 vs. 83%).
CONCLUSION: Patients who began HD with a catheter had more complications and higher mortality. Routine quality assessment of AVF by Doppler ultrasound is recommended.
METHODS: The patients were classified into two groups. Group I, patients in whom venous catheters were inserted (652 patients). Group II, 80 patients with end-stage renal disease (ESRD) in whom an arteriovenous fistula (AVF) was established.
RESULTS: Complications in the femoral approach were bleeding from a femoral artery wall laceration in only 6/600 patients (1%), successfully repaired in all patients, bleeding from a punctured femoral artery in 30 patients (5%), the incidence of infection and removal was 40%. Other complications included groin hematoma in 3 patients (0.5%) and catheter thrombosis in 45 patients (7.5%). In the jugular vein approach, infection occurred in 6/30 patients (20%), thrombosis in 9 patients (30%), and accidental withdrawal in 2 patients (6.7%). In the subclavian vein approach, catheter dysfunction was found in 7/22 patients (32%), infection in 10 patients (45.5%), and failure to cannulate the vein in 3 patients (13.6%). In group II, limb edema was found in 14/80 patients (17.5%), hematoma in 5 patients (6.3%), accidental trauma to the fistula in 2 patients (2.5%) and fistula stenosis in 15 patients (18.8%). Patients who began HD with a catheter had higher mortality than those who began with an AVF (12 months survival, respectively, 60 vs. 83%).
CONCLUSION: Patients who began HD with a catheter had more complications and higher mortality. Routine quality assessment of AVF by Doppler ultrasound is recommended.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app